Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Feb;46(2):493-8.
doi: 10.1128/JCM.01499-07. Epub 2007 Dec 5.

Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipients

Isabelle Garrigue  1 , Adélaïde Doussau, Julien Asselineau, Hélène Bricout, Lionel Couzi, Catherine Rio, Pierre Merville, Hervé Fleury, Marie-Edith Lafon, Rodolphe Thiébaut
Affiliations

Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipients

Isabelle Garrigue et al. J Clin Microbiol. 2008 Feb.

Abstract

In a prospective cohort of 82 renal transplant recipients, we evaluated the capacity of the cytomegalovirus (CMV) load in whole blood (WB) to predict the plasma CMV load, aiming to identify active CMV infections by using WB samples only and to deduce a WB threshold. Using quantitative real-time PCR, a total of 1,474 WB samples were assayed, of which 279 were positive for CMV, and 140 out of the 276 paired plasma samples tested positive. Thirty (36.6%) patients presented with at least one positive plasma PCR result, and 21 infection episodes (19 patients) required curative treatment (median follow-up time, 12 months). When the plasma CMV load was >500 copies/ml (n = 70), more than 94% (95% confidence interval, 86.0%, 98.4%) of WB samples had >500 copies/ml. Two prediction models were built: log(10) plasma viral load (VL) was calculated as -0.3777 + 0.9342 x log(10) WB VL and as -0.3777 + 0.8563 x log(10) WB VL for patients with and without treatment, respectively. In the validation sample (578 routine samples), 77.2% of the observed and expected plasma viral loads were concordant (95% confidence intervals, 73.5 and 80.5%). According to the model, the plasma viral load was >500 copies/ml when the WB load was >3,170 or >4,000 copies/ml in patients with or without treatment, respectively. WB seems to be an appropriate candidate for routine CMV monitoring of transplant recipients by using a single assay.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Follow-up of the 82 patients, with distribution of real-time quantitative PCR results for WB and plasma (PL). cop, copies.
FIG. 2.
FIG. 2.
Prediction of plasma (PL) VL from WB VL (n = 147). cp or cop, copies. Of note, some of the viral DNA loads in plasma were undetectable (i.e., left-censored) and are plotted at the detection limit (2.70 log10 copies/ml); however, they were taken into account as left-censored values in the model (see Materials and Methods).
FIG. 3.
FIG. 3.
Distribution of WB and plasma (PL) real-time quantitative PCR results for the 82 patients without treatment. cop, copies.
See this image and copyright information in PMC

References

    1. Barrett-Muir, W., J. Breuer, C. Millar, J. Thomas, D. Jeffries, M. Yaqoob, and C. Aitken. 2000. CMV viral load measurements in whole blood and plasma—which is best following renal transplantation? Transplantation 70116-119. - PubMed
    1. Boeckh, M., and G. Boivin. 1998. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin. Microbiol. Rev. 11533-554. - PMC - PubMed
    1. Boeckh, M., G. M. Gallez-Hawkins, D. Myerson, J. A. Zaia, and R. A. Bowden. 1997. Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. Transplantation 64108-113. - PubMed
    1. Boivin, G., R. Belanger, R. Delage, C. Beliveau, C. Demers, N. Goyette, and J. Roy. 2000. Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation. J. Clin. Microbiol. 384356-4360. - PMC - PubMed
    1. Caliendo, A. M., K. St George, S. Y. Kao, J. Allega, B. H. Tan, R. LaFontaine, L. Bui, and C. R. Rinaldo. 2000. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. J. Clin. Microbiol. 382122-2127. - PMC - PubMed

Publication types

Substances